2016
DOI: 10.2500/ar.2016.7.0163
|View full text |Cite
|
Sign up to set email alerts
|

Role of Antioxidants on the Clinical Outcome of Patients with Perennial Allergic Rhinitis

Abstract: ABSTRACT

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 41 publications
(55 reference statements)
1
7
0
Order By: Relevance
“…Recent investigations indicate a role of antioxidants/supplements in the treatment of asthma and allergic rhinitis [ 28 , 29 ]. To further investigate this benefit for allergic rhinitis, we performed a double-blind, placebo-controlled study using a sulforaphane-based antioxidant We chose validated Peak Nasal Inspiratory Flow (PNIF) and Total Nasal Symptom Score (TNSS) to measure the four cardinal features of allergic rhinitis: nasal congestion, rhinorrhea, sneezing and ocular/nasal itching [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recent investigations indicate a role of antioxidants/supplements in the treatment of asthma and allergic rhinitis [ 28 , 29 ]. To further investigate this benefit for allergic rhinitis, we performed a double-blind, placebo-controlled study using a sulforaphane-based antioxidant We chose validated Peak Nasal Inspiratory Flow (PNIF) and Total Nasal Symptom Score (TNSS) to measure the four cardinal features of allergic rhinitis: nasal congestion, rhinorrhea, sneezing and ocular/nasal itching [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…The addition of an antioxidant to conventional nasal corticosteroid therapy for allergic rhinitis was proven beneficial in an open-label study [ 29 ]. Our study confirms these findings through analysis of PNIF.…”
Section: Discussionmentioning
confidence: 99%
“…The subjects were randomly allocated into three groups: T0 (Placebo), received starch capsules; T1 (Treatment 1), receiving Ginkgo biloba capsules 60 mg twice a day; and T2 (Treatment 2), receiving Ginkgo biloba capsules 60 mg twice a day along with antioxidant preparation (β-carotene [provitamin A] 20 mg, vitamin C [ascorbic acid] 200 mg, vitamin E 200 mg, and selenium 50 µg). Antioxidant preparation was used from our earlier study [ 15 ].…”
Section: Methodsmentioning
confidence: 99%
“…Antioxidants [38] Antioxidants usually do not trigger nasal discomfort or drug uptake. As portion of the formulated design programmed, chemical / physical interactions of antioxidants and preservatives should be regarded with medication, excipients, manufacturing machinery and packaging elements.…”
Section: Formulation Phmentioning
confidence: 99%
“…[49] A pipette or a squeezed tube can be supplied to the nasal drops. [34][35][36][37][38][39] These are generally suggested for local circumstances, but difficulties include microbial development, mucociliar dysfunction and unspecified nose or neck reduction. [49] A piston and a tube working actuator are the nasal spray devices.…”
Section: Systems Of Nasal Drug Delivery Nasal Drops and Spraysmentioning
confidence: 99%